EJNMMI Research

Scope & Guideline

Advancing the Frontiers of Nuclear Medicine and Imaging.

Introduction

Immerse yourself in the scholarly insights of EJNMMI Research with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN2191-219x
PublisherSPRINGER
Support Open AccessYes
CountryGermany
TypeJournal
Convergefrom 2011 to 2024
AbbreviationEJNMMI RES / EJNMMI Res.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, NY 10004, UNITED STATES

Aims and Scopes

EJNMMI Research is a leading journal that focuses on the advancements and applications of nuclear medicine and molecular imaging. The journal aims to publish high-quality research that enhances the understanding and development of novel imaging techniques and radiopharmaceuticals, contributing to improved diagnostics and therapeutics in various medical fields.
  1. Molecular Imaging Techniques:
    The journal emphasizes innovative imaging modalities, including positron emission tomography (PET), single-photon emission computed tomography (SPECT), and hybrid imaging techniques, which are crucial for diagnosing and monitoring diseases.
  2. Radiopharmaceutical Development:
    A significant focus is on the development and validation of new radiopharmaceuticals for both diagnostic and therapeutic applications, with an aim to improve imaging accuracy and patient outcomes.
  3. Clinical Applications and Trials:
    EJNMMI Research publishes studies that explore the clinical applications of imaging technologies, including their role in oncology, neurology, cardiology, and other fields, as well as the results from clinical trials.
  4. Quantitative Imaging and Dosimetry:
    The journal covers advances in quantitative imaging methodologies and dosimetry, which are essential for optimizing treatment plans in personalized medicine.
  5. Theranostics:
    The integration of diagnostics and therapeutics, or theranostics, is a key area of research, focusing on the use of imaging to guide targeted therapies.
  6. Artificial Intelligence and Imaging:
    There is a growing interest in the application of artificial intelligence and machine learning techniques to enhance imaging analysis and interpretation, which is a significant trend within the journal.
EJNMMI Research has been at the forefront of several emerging themes that reflect the latest advancements in nuclear medicine and molecular imaging. These trends are critical for researchers seeking to understand the future directions of this field.
  1. Artificial Intelligence in Imaging:
    The application of AI and machine learning for image reconstruction, analysis, and interpretation is rapidly gaining traction, as these technologies enhance diagnostic accuracy and efficiency.
  2. Radiomics and Imaging Biomarkers:
    The exploration of radiomics, which involves extracting a large number of features from medical images, is trending as a method for improving diagnosis and predicting treatment outcomes.
  3. Personalized Medicine:
    There is an increasing emphasis on personalized approaches in nuclear medicine, particularly in the context of cancer therapies that are tailored based on individual patient imaging and genetic profiles.
  4. Theranostic Approaches:
    The integration of diagnostic and therapeutic strategies, particularly using radioligands for targeted therapy, is emerging as a significant theme, reflecting the trend toward personalized treatment plans.
  5. Hybrid Imaging Technologies:
    The continued development and application of hybrid imaging technologies, such as PET/MRI and PET/CT, are trending, allowing for comprehensive assessments of complex diseases.
  6. Immuno-PET Techniques:
    The use of immuno-PET for evaluating immune responses and targeting specific biomarkers is gaining popularity, reflecting a broader interest in immunotherapy and its monitoring.

Declining or Waning

While EJNMMI Research continues to thrive in many areas, certain themes have become less prominent in recent publications. This decline may reflect shifts in research focus or advancements rendering previous methodologies less relevant.
  1. Traditional Imaging Techniques:
    There has been a noticeable decrease in publications focused exclusively on traditional imaging methods without the integration of newer technologies or advanced imaging analysis techniques.
  2. Invasive Imaging Procedures:
    Research papers emphasizing invasive imaging procedures are becoming less common as non-invasive techniques gain favor for their lower risk and improved patient comfort.
  3. Basic Science Studies:
    There has been a waning interest in purely basic science studies that do not translate directly to clinical applications, as the journal increasingly prioritizes translational research.
  4. Non-targeted Imaging Agents:
    The focus on non-specific or non-targeted imaging agents is decreasing, with a shift towards more personalized and targeted approaches in imaging.

Similar Journals

SEMINARS IN ULTRASOUND CT AND MRI

Unlocking the Future of Radiology and Imaging
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0887-2171Frequency: 6 issues/year

SEMINARS IN ULTRASOUND CT AND MRI is a prestigious academic journal dedicated to advancing the fields of radiology, nuclear medicine, and imaging. Published by W B SAUNDERS CO-ELSEVIER INC, this journal has been a cornerstone of scholarly communication since 1984, providing a platform for high-quality research and review articles that enhance the understanding of diagnostic imaging techniques. With a current impact factor reflected in its Q3 quartile ranking among 333 journals in its category, it remains a valuable resource for researchers and clinicians alike. The journal's focus includes but is not limited to innovations in ultrasound, computed tomography, and magnetic resonance imaging, making it essential for professionals looking to stay at the forefront of imaging science. While it operates under a subscription model, its extensive archive of influential articles ensures ongoing access to critical knowledge and developments in the field. With a commitment to quality and relevance, SEMINARS IN ULTRASOUND CT AND MRI continues to contribute significantly to the evolving landscape of medical imaging.

Revista Espanola de Medicina Nuclear e Imagen Molecular

Enhancing Knowledge in Nuclear Medicine and Imaging
Publisher: ELSEVIER ESPANA SLUISSN: 2253-654XFrequency: 6 issues/year

Revista Española de Medicina Nuclear e Imagen Molecular, published by Elsevier España SLU, stands as a vital resource in the field of Radiology, Nuclear Medicine, and Molecular Imaging. With an ISSN of 2253-654X, this journal is committed to disseminating high-quality research and advancements in clinical practices, aiming to bridge the gap between theoretical research and application in healthcare. Operating since 2012, it features a robust archive of peer-reviewed articles and case studies, although it currently holds a Q4 ranking in the Scopus category, indicating significant potential for growth and influence within the academic community. The journal is indexed in Scopus, with a rank of 255 out of 333, placing it in the 23rd percentile, which underlines the need for increased contributions from researchers eager to enhance its standing. While it is not an open-access journal, its availability through libraries and institutions ensures that a wide audience can access critical findings and innovations in the rapidly evolving field of nuclear medicine. As we look towards the convergence period from 2012 to 2024, Revista Española de Medicina Nuclear e Imagen Molecular aspires to fortify its role as a cornerstone for collaboration and advancement in nuclear imaging and radiology.

Medecine Nucleaire-Imagerie Fonctionnelle et Metabolique

Unveiling the Science Behind Nuclear Medicine.
Publisher: ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIERISSN: 0928-1258Frequency: 6 issues/year

Medicine Nucleaire-Imagerie Fonctionnelle et Metabolique is a prominent journal published by Elsevier France-Editions Scientifiques Medicales Elsevier, dedicated to the specialized fields of nuclear medicine and functional imaging. With an ISSN of 0928-1258 and an E-ISSN of 1878-6820, this esteemed publication has been a crucial platform for the dissemination of research and developments in the discipline since its inception in 1993. Covering a wide array of topics within biophysics, radiological and ultrasound technology, and radiology, the journal currently holds a Q4 category ranking in these fields, reflecting its significance within the academic community. Although there are currently no open access options available for readers, the journal caters to a niche audience of researchers, professionals, and students who seek to enhance their understanding of metabolic imaging and its applications. The 2023 Scopus ranks indicate its position as an emerging source of knowledge in a competitive landscape, making it an important resource for the latest studies and innovations in nuclear medicine.

Current Cardiovascular Imaging Reports

Transforming Diagnostics through Cutting-edge Imaging Techniques
Publisher: SPRINGERISSN: 1941-9066Frequency: 12 issues/year

Current Cardiovascular Imaging Reports, published by SPRINGER, is a notable academic journal within the field of cardiovascular imaging. With its ISSN 1941-9066 and E-ISSN 1941-9074, this journal has been a critical resource since its inception in 2008, aiming to disseminate high-quality research and reviews in the realm of cardiovascular diagnostics and imaging technologies. Though currently categorized within the Q3 and Q4 quartiles for various fields such as Applied Microbiology and Biotechnology, Histology, and Cell Biology, its impact and relevance are growing steadily. Researchers and practitioners can benefit from the insights presented in this journal, especially as it covers advancements and practical applications in cardiovascular imaging techniques crucial for enhancing patient care. Given its ongoing commitment to open access, although not currently available, readers can engage with significant research findings that may inform future studies and applications in cardiology. With plans to converge towards 2024, this journal is poised to facilitate the exchange of knowledge and foster innovation within its dynamic field.

Clinical Imaging

Innovating Radiology Through Cutting-Edge Research
Publisher: ELSEVIER SCIENCE INCISSN: 0899-7071Frequency: 6 issues/year

Clinical Imaging, published by Elsevier Science Inc, is a renowned journal dedicated to the field of radiology, nuclear medicine, and imaging. With an ISSN of 0899-7071 and an E-ISSN of 1873-4499, this esteemed publication has established its significance in advancing imaging science since its inception in 1989 and continues to make impactful contributions to the discipline through 2024. The journal holds a prestigious Q2 ranking in the category of Radiology, Nuclear Medicine, and Imaging, reflecting its critical role in bridging research and clinical practice. Currently ranked #113 out of 333 by Scopus, with a notable 66th percentile, it offers a platform for disseminating high-quality research, reviews, and case studies that inspire innovation and enhance imaging techniques. Although it primarily functions as a subscription-based journal, it remains dedicated to accessibility and the dissemination of pivotal findings that inform both academia and clinical settings. Clinical Imaging is essential for researchers, professionals, and students alike, offering insights that shape the future of diagnostic imaging.

EJNMMI Physics

Pioneering Research in Radiology and Nuclear Medicine.
Publisher: SPRINGERISSN: 2197-7364Frequency: 1 issue/year

EJNMMI Physics, the premier journal for advancements in nuclear medicine and imaging, is published by Springer in Switzerland and has been an open-access outlet since 2014, allowing for broad dissemination of critical research findings. With an ISSN of 2197-7364, the journal aims to bridge the gap between state-of-the-art physics and practical applications in biomedical engineering and radiology. Its impressive Q1 ranking in multiple categories, including Biomedical Engineering, Instrumentation, Radiation, and Radiology, Nuclear Medicine and Imaging, exemplifies its significant impact in the field. The journal boasts exceptional metrics with Scopus rankings placing it in the top echelons across disciplines, including a 6th position out of 58 in Radiation, and serves as an essential resource for researchers, professionals, and students who are eager to contribute to and stay informed about cutting-edge scientific advancements. With a broadening scope until 2024, EJNMMI Physics is an indispensable tool for those dedicated to pushing the boundaries of knowledge in medical physics and imaging technologies.

SEMINARS IN NUCLEAR MEDICINE

Leading the way in radiology advancements.
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0001-2998Frequency: 6 issues/year

Welcome to Seminars in Nuclear Medicine, a prestigious journal published by W B Saunders Co-Elsevier Inc that has been at the forefront of the field since its inception in 1971. This journal serves as a dedicated forum for researchers, healthcare professionals, and students specializing in the rapidly evolving areas of radiology and nuclear medicine. With an impressive ranking of #29 out of 333 in the Scopus category, drawing an esteemed 91st percentile, it holds a distinguished Q1 category status, highlighting its critical role in disseminating high-quality research and clinical practices. Although it does not operate as an Open Access publication, Seminars in Nuclear Medicine remains a vital resource, featuring comprehensive reviews and insightful articles that inform the medical community about the latest advancements and applications within nuclear imaging. This journal not only enhances knowledge but also encourages collaboration among professionals dedicated to improving patient outcomes through innovative nuclear medicine techniques.

ANNALS OF NUCLEAR MEDICINE

Championing Progress in Radiology and Nuclear Medicine
Publisher: SPRINGERISSN: 0914-7187Frequency: 10 issues/year

ANNALS OF NUCLEAR MEDICINE is a prominent academic journal dedicated to the field of nuclear medicine, published by Springer. With a rich publication history dating back to 1987 and continuing through 2024, this journal serves as a vital resource for researchers and practitioners interested in the latest developments in nuclear imaging, radiopharmaceuticals, and therapeutic applications. Ranked in the second quartile (Q2) for both Medicine (miscellaneous) and Radiology, Nuclear Medicine, and Imaging categories in 2023, it maintains a strong position in the academic community, with an impressive Scopus rank of #104 out of 333 in its field, placing it in the 68th percentile. The journal is not open access but offers a range of access options through institutional or individual subscriptions, ensuring that critical research findings reach a wide audience. By fostering high-quality, peer-reviewed articles, ANNALS OF NUCLEAR MEDICINE plays a crucial role in advancing the understanding and practical application of nuclear medicine techniques, making it an essential journal for professionals and students aiming to stay at the forefront of this evolving discipline.

Egyptian Journal of Radiology and Nuclear Medicine

Championing Open Access to Radiological Advancements
Publisher: SPRINGERISSN: Frequency: 1 issue/year

The Egyptian Journal of Radiology and Nuclear Medicine, published by Springer, is a premier open access journal that has provided valuable insights and advancements in the fields of radiology and nuclear medicine since its initiation in 2010. With an E-ISSN of 2090-4762, this journal is dedicated to bridging the gap between research and clinical practice, allowing for the dissemination of high-quality research to a global audience. Situated in Germany, it enjoys a robust reputation in the academic community, evidenced by its categorization in the Q3 quartile for 2023, as well as its Scopus ranking, where it holds a position of #225 out of 333 in the domain of Radiology, Nuclear Medicine and Imaging, placing it in the 32nd percentile. The journal's open access model ensures that researchers, professionals, and students can freely access innovative studies, reviews, and case reports that discuss the latest methodologies, technological advancements, and clinical outcomes in radiology and nuclear medicine. As it looks toward its converged years spanning from 2010 to 2024, the Egyptian Journal of Radiology and Nuclear Medicine continues to be an essential resource for advancing knowledge and fostering ongoing collaboration in these critical fields.

JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY

Enhancing Radiology with Cutting-Edge Research
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0363-8715Frequency: 6 issues/year

JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, published by Lippincott Williams & Wilkins, stands as a vital resource in the field of Radiology, Nuclear Medicine, and Imaging. Since its inception in 1977, this journal has been dedicated to advancing the understanding and application of computer-assisted tomography, emphasizing innovative research and clinical practices that enhance diagnostic imaging techniques. With an impact factor reflective of its rigorous scholarship and relevance—ranking in the Q3 category—the journal serves as an essential platform for contributors and readers alike, navigating the challenges and opportunities within a rapidly evolving field. Researchers, professionals, and students are encouraged to engage with the rich repository of articles that cover emerging technologies, clinical applications, and theoretical advancements, collectively fostering a deeper comprehension of imaging sciences. Although not currently designated as an open-access journal, it continues to enhance discourse in the community from its headquarters in Philadelphia, PA, maintaining a commitment to the highest standards of academic excellence.